The stock market dropped sharply in recent days as investors worried about the effects of President Donald Trump’s new tariffs on Canada and Mexico.
Related Posts
Never mind the 60/40 portfolio. There may be a case for a 50/30/20 allocation
Investors seeking to diversify from a stock and bond market that are each flashing cautionary signals are starting to look at alternatives.
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea, expanding use in U.S.
The agency’s decision expands the use of Zepbound and could potentially pave the way for Eli Lilly to gain broader insurance coverage for the treatment.
SEC revokes unpopular banking rule that blocked Wall Street banks from adopting crypto
SEC rescinds controversial rule in latest pro-crypto measure taken by new Trump administration.